Illumina, Inc.
At Illumina, our mission is to improve human health by unlocking the power of the genome. Our sequencing by synthesis chemistry is used to generate high-accuracy sequence data in studies around the globe. Our microarrays also provide accurate, high-throughput genotyping for a range of applications. The innovative products that we provide are facilitating breakthroughs in many scientific areas, including oncology, reproductive health, genetic disease, precision medicine, agriculture, microbiology, and beyond. The progress we see being made in genomics inspires us to push the boundaries of what is possible so we can create the next generation of genomics solutions.
Latest Content
Redefining the Impossible With Genomics
Streamline Somatic Variant Interpretation
Illumina Connected Insights
Break Through the NGS Interpretation Bottleneck To Improve Patient Outcomes
Simultaneous Profiling of the Epigenome and Transcriptome at a Single-Cell Level
New State-of-the-Art Genomic Services Facility Opening in the UK
Veracyte Announces In Vitro Diagnostic Agreement With Illumina
Partnerships Provide Automated Library Preparation Solutions
Eremid® Genomic Services Expands Long-Read HiFi Sequencing Capabilities With PacBio Revio